Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE The factors independently associated with cirrhosis were albumin concentration [odds ratio (OR), 0.69; 95% confidence interval (CI), 0.58-0.83; <i>p</i> < .0001] and visceral fat accumulation (OR, 1.02; 95% CI, 1.01-1.04; <i>p</i> = .0003). 31564109 2020
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. 31394283 2020
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE To assess the benefits and harms of any plasma volume expanders such as albumin, other colloids (polygeline, dextrans, hydroxyethyl starch solutions, fresh frozen plasma), intravenous infusion of ascitic fluid, crystalloids, or mannitol versus no plasma volume expander or versus another plasma volume expander for paracentesis in people with cirrhosis and large ascites. 31251387 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE In fact, patients with liver cirrhosis present posttranslational modifications on albumin that compromises its function. 29893696 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Albumin infusion reduces the incidence of postparacentesis circulatory dysfunction among patients with cirrhosis and tense ascites compared with no treatment. 30312183 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites. 30230204 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Use of albumin therapy is recommended for management of disease complications in cirrhosis. 30700489 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE We aimed to elucidate the prognostic impact of this Zn classification system in patients with liver cirrhosis (LC) compared to the Child-Pugh classification and the albumin-bilirubin (ALBI) grading system (<i>n</i> = 441, median age = 66 years). 31766742 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 AlteredExpression disease BEFREE MVI, older age, lower albumin levels, and cirrhosis were risk factors for overall survival. 30117236 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Based on the results of our retrospective study and meta-analysis, albumin infusion might prevent from the occurrence of overt HE and improve the severity of overt HE in cirrhosis. 31596729 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE However, presence of autoantibodies against albumin in patients with liver cirrhosis has been described. 30930689 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 AlteredExpression disease BEFREE Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization. 31636711 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Albumin-bilirubin (ALBI) grade was investigated to predict prognosis of patients with cirrhosis. 30892804 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Combined Albumin-Bilirubin Grade and Skeletal Muscle Mass as a Predictor in Liver Cirrhosis. 31159435 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Mean arterial pressure (MAP), platelet count, and serum albumin were significantly lower and total leucocyte count (TLC), blood urea nitrogen, serum creatinine (SCr), total bilirubin, aspartate aminotransferase, international normalized ratio, Child-Turcotte-Pugh (CTP) score, and model for end-stage liver disease (MELD) score higher in cirrhosis patients with AKI than without AKI (p < 0.05 each). 31830752 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 GeneticVariation disease BEFREE In a multivariable logistic regression analysis, liver cirrhosis (adjusted odds ratio [aOR], 13.7; 95% confidence interval [CI], 2.9-67.0), treatment with antibiotics without surgery (aOR, 10.2; 95% CI, 2.1-48.3), and lower level of albumin (aOR 4.9; 95% CI, 1.6-14.9) were associated with 30-day mortality. 30713116 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Paracentesis-induced circulatory dysfunction (PICD) is a serious complication of large-volume (>5 L) paracentesis in cirrhosis and is reduced with albumin infusion. 31849085 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis. 30765220 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE In the derivation dataset, we identified four factors associated with HCC, namely, age, albumin, sex, and liver cirrhosis. 30694912 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Hence, PUFAs and co-factors needed for their metabolism and albumin may be of benefit in the prevention and management of HBV, HCV, alcoholic hepatitis and NAFLD, and liver cirrhosis. 31193303 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis. 31498284 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Although the results of these studies may appear conflicting, their analyses suggest that albumin, if given in a sufficient amount and for a sufficient duration, can significantly reduce the incidence of life-threatening complications of cirrhosis and patient mortality. 30346096 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE Univariate analysis identified three factors to be significantly associated with BDI-I score ≥11: Our classification (groups of A, B, C, and D) (<i>p</i> = 0.0259), serum albumin (<i>p</i> = 0.0445), and the presence of LC (<i>p</i> = 0.0157). 31072067 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE At SVR24, higher baseline ARFI values (P=0.038) were associated with a decrease in LSM in patients with cirrhosis versus normal international normalization ratio (P=0.003), lower bilirubin (P=0.003), and higher albumin (P=0.007) in patients without cirrhosis. 30239347 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.400 Biomarker disease BEFREE The albumin-bilirubin (ALBI) score was originally established to stratify prognosis in patients with cirrhosis. 31115300 2019